Literature DB >> 14600258

RNAi analysis reveals an unexpected role for topoisomerase II in chromosome arm congression to a metaphase plate.

Chih-Jui Chang1, Sarah Goulding, William C Earnshaw, Mar Carmena.   

Abstract

DNA topoisomerase II (Topo II) is a major component of mitotic chromosomes and an important drug target in cancer chemotherapy, however, its role in chromosome structure and dynamics remains controversial. We have used RNAi to deplete Topo II in Drosophila S2 cells in order to carry out a detailed functional analysis of the role of the protein during mitosis. We find that Topo II is not required for the assembly of a functional kinetochore or the targeting of chromosomal passenger proteins, nonetheless, it is essential for anaphase sister chromatid separation. In response to a long-running controversy, we show that Topo II does have some role in mitotic chromatin condensation. Chromosomes formed in its absence have a 2.5-fold decrease in the level of chromatin compaction, and are morphologically abnormal. However, it is clear that the overall programme of mitotic chromosome condensation can proceed without Topo II. Surprisingly, in metaphase cells depleted of Topo II, one or more chromosome arms frequently stretch out from the metaphase plate to the vicinity of the spindle pole. This is not kinetochore-based movement, as the centromere of the affected chromosome is located on the plate. This observation raises the possibility that further unexpected functions for Topo II may remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600258     DOI: 10.1242/jcs.00797

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  38 in total

Review 1.  Topoisomerase II: untangling its contribution at the centromere.

Authors:  Andrew C G Porter; Christine J Farr
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  Centromeric protein bodies on avian lampbrush chromosomes contain a protein detectable with an antibody against DNA topoisomerase II.

Authors:  Alla Krasikova; Tatiana Kulikova; Alsu Saifitdinova; Svetlana Derjusheva; Elena Gaginskaya
Journal:  Chromosoma       Date:  2004-11-17       Impact factor: 4.316

Review 3.  Kiss and break up--a safe passage to anaphase in mitosis and meiosis.

Authors:  Jeffrey M Craig; K H Andy Choo
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

4.  Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.

Authors:  Jennifer M Spence; Hui Hui Phua; Walter Mills; Adam J Carpenter; Andrew C G Porter; Christine J Farr
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

Review 5.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

6.  Mitotic chromosomes are constrained by topoisomerase II-sensitive DNA entanglements.

Authors:  Ryo Kawamura; Lisa H Pope; Morten O Christensen; Mingxuan Sun; Ksenia Terekhova; Fritz Boege; Christian Mielke; Anni H Andersen; John F Marko
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

7.  Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line.

Authors:  Adam J Carpenter; Andrew C G Porter
Journal:  Mol Biol Cell       Date:  2004-09-29       Impact factor: 4.138

8.  Disruption of topoisomerase II perturbs pairing in drosophila cell culture.

Authors:  Benjamin R Williams; Jack R Bateman; Natasha D Novikov; C-Ting Wu
Journal:  Genetics       Date:  2007-09       Impact factor: 4.562

9.  pRb and condensin--local control of global chromosome structure.

Authors:  Brigitte D Lavoie
Journal:  Genes Dev       Date:  2008-04-15       Impact factor: 11.361

Review 10.  Topoisomerase II: a fitted mechanism for the chromatin landscape.

Authors:  Joaquim Roca
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.